Literature DB >> 24518802

A national survey on the initial management of upper gastrointestinal bleeding.

Peter S Liang1, John R Saltzman.   

Abstract

GOALS: To evaluate the initial management of upper gastrointestinal (GI) bleeding in the United States.
BACKGROUND: Various guidelines have addressed the initial management of upper GI bleeding, but the extent to which these guidelines are followed in clinical practice is unknown. STUDY: We conducted a national survey of emergency physicians, internists, and gastroenterologists practicing in hospitals affiliated with an ACGME-accredited gastroenterology fellowship. Participants rated their agreement and adherence to 9 preendoscopic quality indicators for the initial management of upper GI bleeding. Awareness, use, and barriers to the use of early prognostic risk scores were also assessed.
RESULTS: A total of 1402 surveys were completed, with an estimated response rate of 11.3%. Gastroenterologists and trainees agreed with the quality indicators more than nongastroenterologists and attending physicians, respectively. There was no difference in the application of the quality indicators by specialty or clinical position. Among all physicians, 53% had ever heard of and 30% had ever used an upper GI bleeding risk score. More gastroenterologists than nongastroenterologists had heard of (82% vs. 44%, P<0.001) and used (51% vs. 23%, P<0.001) a risk score. There was no difference between attending physicians and trainees. Gastroenterologists and attending physicians more often cited lack of utility as a reason to not use risk scores, whereas nongastroenterologists and trainees more often cited lack of knowledge.
CONCLUSIONS: Among emergency physicians, internists, and gastroenterologists in the United States, agreement with upper GI bleeding initial management guidelines was high but adherence--especially pertaining to the use of risk scores--was low.

Entities:  

Mesh:

Year:  2014        PMID: 24518802     DOI: 10.1097/MCG.0000000000000095

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  6 in total

1.  Scoring systems for upper gastrointestinal bleeding: Which one scores better?

Authors:  Vinay Dhir; Rahul Shah
Journal:  Indian J Gastroenterol       Date:  2019-04

2.  Early lactate clearance for predicting outcomes in patients with gastrointestinal bleeding.

Authors:  Keon Kim; Dong Hoon Lee; Duk Hee Lee; Yoon Hee Choi; Sung Jin Bae
Journal:  Ir J Med Sci       Date:  2022-10-13       Impact factor: 2.089

3.  Factors Associated with Rebleeding in Patients with Peptic Ulcer Bleeding: Analysis of the Korean Peptic Ulcer Bleeding (K-PUB) Study.

Authors:  Joon Sung Kim; Byung-Wook Kim; Sung Min Park; Ki-Nam Shim; Seong Woo Jeon; Sang-Wook Kim; Yong Chan Lee; Hee Seok Moon; Si Hyung Lee; Woon Tae Jung; Jin Il Kim; Kyoung Oh Kim; Jong-Jae Park; Woo Chul Chung; Jeong Hwan Kim; Gwang Ho Baik; Jung Hwan Oh; Sun Moon Kim; Hyun Soo Kim; Chang Heon Yang; Jin Tae Jung; Chul Hyun Lim; Hyun Joo Song; Yong Sik Kim; Gwang Ha Kim; Jie-Hyun Kim; Jae-Il Chung; Jun Haeng Lee; Min Ho Choi; Jong-Kyoung Choi
Journal:  Gut Liver       Date:  2018-05-15       Impact factor: 4.519

4.  Lactic Acid Is an Independent Predictor of Mortality and Improves the Predictive Value of Existing Risk Scores in Patients Presenting With Acute Gastrointestinal Bleeding.

Authors:  Matthew Berger; Vadim Divilov; Getu Teressa
Journal:  Gastroenterology Res       Date:  2019-02-26

5.  Glasgow Blatchford Score of limited benefit for low-risk urban patients: a mixed methods study.

Authors:  David A Leiman; Angela M Mills; Frances S Shofer; Andrew T Weber; Erin R Leiman; Brian P Riff; James D Lewis; Shivan J Mehta
Journal:  Endosc Int Open       Date:  2017-09-29

6.  Semiautomated Glasgow-Blatchford Bleeding Score helps direct bed placement for patients with upper gastrointestinal bleeding.

Authors:  Drew B Schembre; Robson E Ely; Janice M Connolly; Kunjali T Padhya; Rohit Sharda; John J Brandabur
Journal:  BMJ Open Gastroenterol       Date:  2020-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.